Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 9/20 | 0.68 |
| ▸ | FAAH | O00519 | 14/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25829844 | 0.92 | MGLL (0.67) | MGLLFAAH | |
| SCHEMBL20567372 | 0.92 | MGLL (0.80) | MGLLFAAH | |
| SCHEMBL30420687 | 0.92 | MGLL (0.80) | MGLLFAAH | |
| SCHEMBL25829816 | 0.91 | FAAH (0.75) | MGLLFAAHKDM4EALDH1A1LMNA | |
| SCHEMBL25829922 | 0.90 | FAAH (0.68) | MGLLFAAHKDM4EALDH1A1LMNA | |
| SCHEMBL25830264 | 0.89 | MGLL (0.85) | MGLLFAAH | |
| SCHEMBL25830174 | 0.89 | FAAH (0.68) | MGLLFAAH | |
| SCHEMBL25829964 | 0.88 | FAAH (0.84) | MGLLFAAH | |
| SCHEMBL25830247 | 0.88 | FAAH (0.71) | MGLLFAAH | |
| SCHEMBL25830126 | 0.87 | FAAH (0.64) | MGLLFAAHKDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | MGLL, PNLIP, LPL | MGLL 1/4885FAAH 33/4885KDM4E 3347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.